Replies to post #126 on Monument Circle Acquisition Corp (MON)

[DewDiligence]

perhaps, Fraley is talking about what is available from the lab and the others are talking about the number of varieties they have decided to commercialize.

I just listened to Fraley’s presentation at the biennial Investor Day in November and I think it’s clear he was talking about RR2Y varieties in the lab rather than in commercial products. The former set of numbers ought to be irrelevant to investors (other than as a curiosity item), so I find it bizarre that Fraley said what he did. Regards, Dew